Cargando…
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
OBJECTIVES: The rarity of early diffuse cutaneous systemic sclerosis (dcSSc) makes randomised controlled trials very difficult. We aimed to use an observational approach to compare effectiveness of currently used treatment approaches. METHODS: This was a prospective, observational cohort study of ea...
Ejemplares similares
-
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
por: Peytrignet, Sébastien, et al.
Publicado: (2018) -
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
por: Herrick, Ariane L, et al.
Publicado: (2018) -
A broad look into the future of systemic
sclerosis
por: Riemekasten, Gabriela, et al.
Publicado: (2022) -
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
por: Hesselstrand, Roger, et al.
Publicado: (2021) -
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
por: Jaeger, Veronika K., et al.
Publicado: (2016)